Published in J Proteome Res on September 08, 2011
Antigen-specific acquired immunity in human brucellosis: implications for diagnosis, prognosis, and vaccine development. Front Cell Infect Microbiol (2012) 1.52
Immune profiling with a Salmonella Typhi antigen microarray identifies new diagnostic biomarkers of human typhoid. Sci Rep (2013) 1.20
Pre-erythrocytic antibody profiles induced by controlled human malaria infections in healthy volunteers under chloroquine prophylaxis. Sci Rep (2013) 1.06
Towards High-throughput Immunomics for Infectious Diseases: Use of Next-generation Peptide Microarrays for Rapid Discovery and Mapping of Antigenic Determinants. Mol Cell Proteomics (2015) 1.01
Identification of seroreactive proteins of Leptospira interrogans serovar copenhageni using a high-density protein microarray approach. PLoS Negl Trop Dis (2013) 1.01
Overview of protein microarrays. Curr Protoc Protein Sci (2013) 0.99
Analyses of Brucella pathogenesis, host immunity, and vaccine targets using systems biology and bioinformatics. Front Cell Infect Microbiol (2012) 0.97
Serial kinetics of the antibody response against the complete Brucella melitensis ORFeome in focal vertebral brucellosis. J Clin Microbiol (2012) 0.89
Pemphigus vulgaris autoantibody profiling by proteomic technique. PLoS One (2013) 0.86
Diagnostic peptide discovery: prioritization of pathogen diagnostic markers using multiple features. PLoS One (2012) 0.85
A foodborne outbreak of brucellosis at a police station cafeteria, Lima, Peru. Am J Trop Med Hyg (2013) 0.84
Translational research in infectious disease: current paradigms and challenges ahead. Transl Res (2012) 0.83
Predicting antigenicity of proteins in a bacterial proteome; a protein microarray and naïve Bayes classification approach. Chem Biodivers (2012) 0.82
Functional protein microarray as molecular decathlete: a versatile player in clinical proteomics. Proteomics Clin Appl (2012) 0.81
A Pneumococcal Protein Array as a Platform to Discover Serodiagnostic Antigens Against Infection. Mol Cell Proteomics (2015) 0.81
Proteomic features predict seroreactivity against leptospiral antigens in leptospirosis patients. J Proteome Res (2014) 0.79
A protein-conjugate approach to develop a monoclonal antibody-based antigen detection test for the diagnosis of human brucellosis. PLoS Negl Trop Dis (2014) 0.78
A systems biology approach for diagnostic and vaccine antigen discovery in tropical infectious diseases. Curr Opin Infect Dis (2015) 0.78
T cell antigen discovery using soluble vaccinia proteome reveals recognition of antigens with both virion and nonvirion association. J Immunol (2014) 0.77
Identification of novel Mycobacterium tuberculosis CD4 T-cell antigens via high throughput proteome screening. Tuberculosis (Edinb) (2015) 0.76
Brucella melitensis T cell epitope recognition in humans with brucellosis in Peru. Infect Immun (2013) 0.75
On Brucella pathogenesis: looking for the unified challenge in systems and synthetic biology. Syst Synth Biol (2014) 0.75
The impact of "omic" and imaging technologies on assessing the host immune response to biodefence agents. J Immunol Res (2014) 0.75
Evaluation of quantum dot immunofluorescence and a digital CMOS imaging system as an alternative to conventional organic fluorescence dyes and laser scanning for quantifying protein microarrays. Proteomics (2016) 0.75
Identification of Novel Serodiagnostic Signatures of Typhoid Fever Using a Salmonella Proteome Array. Front Microbiol (2017) 0.75
Sustained and differential antibody responses to virulence proteins of Brucella melitensis during acute and chronic infections in human brucellosis. Eur J Clin Microbiol Infect Dis (2012) 0.75
Improved prediction of signal peptides: SignalP 3.0. J Mol Biol (2004) 48.40
Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics (2002) 20.59
The new global map of human brucellosis. Lancet Infect Dis (2006) 12.83
Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics (2005) 10.67
Brucellosis. N Engl J Med (2005) 9.97
A new and improved microassay to determine 2-keto-3-deoxyoctonate in lipopolysaccharide of Gram-negative bacteria. Anal Biochem (1978) 7.69
PSORTb v.2.0: expanded prediction of bacterial protein subcellular localization and insights gained from comparative proteome analysis. Bioinformatics (2004) 7.15
Evaluation of methods for the prediction of membrane spanning regions. Bioinformatics (2001) 6.53
A variance-stabilizing transformation for gene-expression microarray data. Bioinformatics (2002) 5.44
An overview of human brucellosis. Clin Infect Dis (1995) 5.30
Human brucellosis. Lancet Infect Dis (2007) 4.92
Improved statistical inference from DNA microarray data using analysis of variance and a Bayesian statistical framework. Analysis of global gene expression in Escherichia coli K12. J Biol Chem (2001) 4.35
Protein abundance profiling of the Escherichia coli cytosol. BMC Genomics (2008) 3.78
A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray. Proc Natl Acad Sci U S A (2010) 2.90
The analysis of the intramacrophagic virulome of Brucella suis deciphers the environment encountered by the pathogen inside the macrophage host cell. Proc Natl Acad Sci U S A (2002) 2.57
Review of clinical and laboratory features of human brucellosis. Indian J Med Microbiol (2007) 2.32
Hypoferremia in mice and its application to the bioassay of endotoxin. J Bacteriol (1965) 2.25
The cloning, expression, and nucleotide sequence of a gene coding for an immunogenic Brucella abortus protein. Gene (1988) 2.17
A genome-wide proteome array reveals a limited set of immunogens in natural infections of humans and white-footed mice with Borrelia burgdorferi. Infect Immun (2008) 2.15
Dynamic antibody responses to the Mycobacterium tuberculosis proteome. Proc Natl Acad Sci U S A (2010) 2.12
Proteome-wide analysis of the serological response to vaccinia and smallpox. Proteomics (2007) 2.10
A Burkholderia pseudomallei protein microarray reveals serodiagnostic and cross-reactive antigens. Proc Natl Acad Sci U S A (2009) 2.10
Immunodominant Francisella tularensis antigens identified using proteome microarray. Proteomics (2007) 1.85
Reverse vaccinology, a genome-based approach to vaccine development. Vaccine (2001) 1.82
From protein microarrays to diagnostic antigen discovery: a study of the pathogen Francisella tularensis. Bioinformatics (2007) 1.68
Identification of humoral immune responses in protein microarrays using DNA microarray data analysis techniques. Bioinformatics (2006) 1.65
Toward a protein profile of Escherichia coli: comparison to its transcription profile. Proc Natl Acad Sci U S A (2003) 1.60
An Equivalence Between Sparse Approximation and Support Vector Machines. Neural Comput (1998) 1.47
Identification of an immunoreactive Brucella abortus HtrA stress response protein homolog. Infect Immun (1994) 1.47
Cloning of Brucella abortus gene and characterization of expressed 26-kilodalton periplasmic protein: potential use for diagnosis. J Clin Microbiol (1996) 1.46
Humoral immune responses of Brucella-infected cattle, sheep, and goats to eight purified recombinant Brucella proteins in an indirect enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol (1997) 1.39
Molecular cloning, nucleotide sequence, and occurrence of a 16.5-kilodalton outer membrane protein of Brucella abortus with similarity to pal lipoproteins. Infect Immun (1994) 1.39
Cloning of a Brucella melitensis group 3 antigen gene encoding Omp28, a protein recognized by the humoral immune response during human brucellosis. Infect Immun (1996) 1.24
Cloning, nucleotide sequence, and expression of the Brucella melitensis bp26 gene coding for a protein immunogenic in infected sheep. FEMS Microbiol Lett (1996) 1.22
Candidate antigens for Q fever serodiagnosis revealed by immunoscreening of a Coxiella burnetii protein microarray. Clin Vaccine Immunol (2008) 1.22
Selection of protective epitopes for Brucella melitensis by DNA vaccination. Infect Immun (2005) 1.18
DNA microarray normalization methods can remove bias from differential protein expression analysis of 2D difference gel electrophoresis results. Bioinformatics (2004) 1.17
Enzyme-linked immunosorbent assay with partially purified cytosoluble 28-kilodalton protein for serological differentiation between Brucella melitensis-infected and B. melitensis Rev.1-vaccinated sheep. Clin Diagn Lab Immunol (1996) 1.16
Proteomic analysis of Brucella abortus cell envelope and identification of immunogenic candidate proteins for vaccine development. Proteomics (2006) 1.14
Intracellular adaptation of Brucella abortus. J Proteome Res (2009) 1.13
Sensitive silver-staining detection of bacterial lipopolysaccharides in polyacrylamide gels. J Biochem Biophys Methods (1993) 1.10
Extensive cell envelope modulation is associated with virulence in Brucella abortus. J Proteome Res (2007) 1.09
Large scale immune profiling of infected humans and goats reveals differential recognition of Brucella melitensis antigens. PLoS Negl Trop Dis (2010) 1.08
Molecular characterization, occurrence, and immunogenicity in infected sheep and cattle of two minor outer membrane proteins of Brucella abortus. Infect Immun (1996) 1.08
Schistosomiasis vaccine discovery using immunomics. Parasit Vectors (2010) 1.03
Identification of the feline humoral immune response to Bartonella henselae infection by protein microarray. PLoS One (2010) 1.03
An in vivo high-throughput screening approach targeting the type IV secretion system component VirB8 identified inhibitors of Brucella abortus 2308 proliferation. Infect Immun (2010) 1.00
Quantitative analysis of the intramacrophagic Brucella suis proteome reveals metabolic adaptation to late stage of cellular infection. Proteomics (2008) 1.00
Designing deep sequencing experiments: detecting structural variation and estimating transcript abundance. BMC Genomics (2010) 1.00
Cell-mediated immunity in human brucellosis. Microbes Infect (2010) 0.99
High-throughput profiling of the humoral immune responses against thirteen human papillomavirus types by proteome microarrays. Virology (2010) 0.99
High-throughput prediction of protein antigenicity using protein microarray data. Bioinformatics (2010) 0.97
An oligopeptide transporter of Mycobacterium tuberculosis regulates cytokine release and apoptosis of infected macrophages. PLoS One (2010) 0.94
Proteomics-based confirmation of protein expression and correction of annotation errors in the Brucella abortus genome. BMC Genomics (2010) 0.92
Evaluation and importance of selected microbiological methods in the diagnosis of human brucellosis. Bosn J Basic Med Sci (2009) 0.90
Analysis of known bacterial protein vaccine antigens reveals biased physical properties and amino acid composition. Comp Funct Genomics (2003) 0.89
Cloning and nucleotide sequence of the Brucella abortus groE operon. Biochim Biophys Acta (1992) 0.88
VirB12 is a serological marker of Brucella infection in experimental and natural hosts. Clin Vaccine Immunol (2007) 0.84
Induction of specific T-helper and cytolytic responses to epitopes displayed on a virus-like protein scaffold derived from the pyruvate dehydrogenase multienzyme complex. Vaccine (2003) 0.84
[Comparison of the serological tests used for the laboratory diagnosis of brucellosis]. Mikrobiyol Bul (2005) 0.83
Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med (2010) 32.89
Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis (2003) 15.02
Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med (2006) 8.39
Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature (2010) 6.25
Taenia solium cysticercosis. Lancet (2003) 5.89
A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med (2004) 5.75
Evaluation and treatment of chagas disease in the United States: a systematic review. JAMA (2007) 5.22
Multidrug-resistant tuberculosis and culture conversion with bedaquiline. N Engl J Med (2014) 4.95
Human brucellosis. Lancet Infect Dis (2007) 4.92
Effects of stunting, diarrhoeal disease, and parasitic infection during infancy on cognition in late childhood: a follow-up study. Lancet (2002) 4.90
Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study. J Acquir Immune Defic Syndr (2007) 4.67
Multi-country analysis of the effects of diarrhoea on childhood stunting. Int J Epidemiol (2008) 4.46
Effect of water and sanitation on childhood health in a poor Peruvian peri-urban community. Lancet (2004) 4.36
Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell Host Microbe (2009) 4.20
Critical function for Naip5 in inflammasome activation by a conserved carboxy-terminal domain of flagellin. Nat Immunol (2008) 4.08
Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis (2007) 3.80
Natural ventilation for the prevention of airborne contagion. PLoS Med (2007) 3.73
The effect of deforestation on the human-biting rate of Anopheles darlingi, the primary vector of Falciparum malaria in the Peruvian Amazon. Am J Trop Med Hyg (2006) 3.72
Prevention and control of cystic echinococcosis. Lancet Infect Dis (2007) 3.64
Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. Proc Natl Acad Sci U S A (2005) 3.59
Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science (2013) 3.54
Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev (2002) 3.37
Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. J Clin Microbiol (2004) 3.27
Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme. Int J Epidemiol (2007) 3.22
Functional adaptation of BabA, the H. pylori ABO blood group antigen binding adhesin. Science (2004) 3.06
Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study. Lancet Neurol (2008) 3.04
Intestinal inflammation allows Salmonella to use ethanolamine to compete with the microbiota. Proc Natl Acad Sci U S A (2011) 2.98
A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray. Proc Natl Acad Sci U S A (2010) 2.90
Clustered local transmission and asymptomatic Plasmodium falciparum and Plasmodium vivax malaria infections in a recently emerged, hypoendemic Peruvian Amazon community. Malar J (2005) 2.77
Clinical spectrum of pulmonary involvement in leptospirosis in a region of endemicity, with quantification of leptospiral burden. Clin Infect Dis (2005) 2.75
Diagnostic approaches for paediatric tuberculosis by use of different specimen types, culture methods, and PCR: a prospective case-control study. Lancet Infect Dis (2010) 2.69
Linking deforestation to malaria in the Amazon: characterization of the breeding habitat of the principal malaria vector, Anopheles darlingi. Am J Trop Med Hyg (2009) 2.64
Injection of flagellin into the host cell cytosol by Salmonella enterica serotype Typhimurium. J Biol Chem (2007) 2.61
Arboviral etiologies of acute febrile illnesses in Western South America, 2000-2007. PLoS Negl Trop Dis (2010) 2.60
Triosephosphate isomerase gene characterization and potential zoonotic transmission of Giardia duodenalis. Emerg Infect Dis (2003) 2.46
Endemic malaria in the Peruvian Amazon region of Iquitos. Am J Trop Med Hyg (2003) 2.43
Selective CD4+ T cell help for antibody responses to a large viral pathogen: deterministic linkage of specificities. Immunity (2008) 2.43
Species identification after treatment for human taeniasis. Lancet (2004) 2.43
Profiling humoral immune responses to P. falciparum infection with protein microarrays. Proteomics (2008) 2.43
Multiple norovirus infections in a birth cohort in a Peruvian Periurban community. Clin Infect Dis (2013) 2.37
The detection of airborne transmission of tuberculosis from HIV-infected patients, using an in vivo air sampling model. Clin Infect Dis (2007) 2.28
Utility of quantitative polymerase chain reaction in leptospirosis diagnosis: association of level of leptospiremia and clinical manifestations in Sri Lanka. Clin Infect Dis (2012) 2.23
Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice. J Virol (2005) 2.18
Mortality during the first year of potent antiretroviral therapy in HIV-1-infected patients in 7 sites throughout Latin America and the Caribbean. J Acquir Immune Defic Syndr (2009) 2.15
A genome-wide proteome array reveals a limited set of immunogens in natural infections of humans and white-footed mice with Borrelia burgdorferi. Infect Immun (2008) 2.15
Dynamic antibody responses to the Mycobacterium tuberculosis proteome. Proc Natl Acad Sci U S A (2010) 2.12
Prolonged infectiousness of tuberculosis patients in a directly observed therapy short-course program with standardized therapy. Clin Infect Dis (2010) 2.11
Neurocysticercosis: A natural human model of epileptogenesis. Epilepsia (2014) 2.11
Proteome-wide analysis of the serological response to vaccinia and smallpox. Proteomics (2007) 2.10
A Burkholderia pseudomallei protein microarray reveals serodiagnostic and cross-reactive antigens. Proc Natl Acad Sci U S A (2009) 2.10
New concepts in the diagnosis and management of neurocysticercosis (Taenia solium). Am J Trop Med Hyg (2005) 2.10
Strongyloides hyperinfection syndrome: an emerging global infectious disease. Trans R Soc Trop Med Hyg (2008) 2.09
The infectiousness of tuberculosis patients coinfected with HIV. PLoS Med (2008) 2.08
Detection of Taenia solium antigens and anti-T. solium antibodies in paired serum and cerebrospinal fluid samples from patients with intraparenchymal or extraparenchymal neurocysticercosis. J Infect Dis (2009) 2.06
Tuberculosis mortality, drug resistance, and infectiousness in patients with and without HIV infection in Peru. Am J Trop Med Hyg (2006) 2.05
Can the power of mobile phones be used to improve tuberculosis diagnosis in developing countries? Trans R Soc Trop Med Hyg (2008) 2.01
Randomized, double-blind, multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases. Antimicrob Agents Chemother (2002) 2.00
Life in the inflamed intestine, Salmonella style. Trends Microbiol (2009) 1.97
Cryptosporidium species and subtypes and clinical manifestations in children, Peru. Emerg Infect Dis (2008) 1.96
Environmental exposure and leptospirosis, Peru. Emerg Infect Dis (2004) 1.96
The laboratory diagnosis and follow up of strongyloidiasis: a systematic review. PLoS Negl Trop Dis (2013) 1.96
Helicobacter pylori CagA phosphorylation-independent function in epithelial proliferation and inflammation. Cell Host Microbe (2009) 1.96
Cutaneous tuberculosis. Clin Dermatol (2007) 1.92
Determining risk for severe leptospirosis by molecular analysis of environmental surface waters for pathogenic Leptospira. PLoS Med (2006) 1.92
Effects of acute diarrhea on linear growth in Peruvian children. Am J Epidemiol (2003) 1.90
Human leptospirosis caused by a new, antigenically unique Leptospira associated with a Rattus species reservoir in the Peruvian Amazon. PLoS Negl Trop Dis (2008) 1.87
Periurban Trypanosoma cruzi-infected Triatoma infestans, Arequipa, Peru. Emerg Infect Dis (2006) 1.85
Immunodominant Francisella tularensis antigens identified using proteome microarray. Proteomics (2007) 1.85
Sustained antiretroviral effect of raltegravir after 96 weeks of combination therapy in treatment-naive patients with HIV-1 infection. J Acquir Immune Defic Syndr (2009) 1.83
Congenital Trypanosoma cruzi transmission in Santa Cruz, Bolivia. Clin Infect Dis (2009) 1.81
Rapid dissemination and diversity of CTX-M extended-spectrum beta-lactamase genes in commensal Escherichia coli isolates from healthy children from low-resource settings in Latin America. Antimicrob Agents Chemother (2007) 1.81
Amazonian malaria: asymptomatic human reservoirs, diagnostic challenges, environmentally driven changes in mosquito vector populations, and the mandate for sustainable control strategies. Acta Trop (2011) 1.78